<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="25554" whole_study_id="25554" phs="001399" v="1" p="1" createDate="2017-06-12T15:07:51-05:00" completedByGPADate="2017-06-15T13:57:43-05:00" modDate="2019-04-18T12:54:25-05:00" maxParentChildStudyModDate="2019-04-18T12:54:25-05:00" handle="Neoadjuvant_Adjuvant_Therapies" num_participants="20"><StudyInfo accession="phs001399.v1.p1" parentAccession="phs001399.v1.p1"><BioProject id="PRJNA392769" entrez_id="392769" type="bp_admin_access"/><BioProject id="PRJNA392770" entrez_id="392770" type="bp_data_submission"/><StudyNameEntrez>Development of Precision Neoadjuvant-Adjuvant Therapies</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>rna</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="2001844380" aid="1" auth="cit" login="sowalskyag" fname="Adam" mname="G" lname="Sowalsky" email="adam.sowalsky@nih.gov"><Role>PI</Role><Organization>NIH</Organization></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011415317" aid="1" auth="cit" login="calzonek" fname="Kathleen" mname="Anne" lname="Calzone" email="calzonek@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>We thank the patients and their families who were willing to participate in this study. This research was supported by funding from the U.S. Department of Defense, the DF/HCC SPORE NIH P50 CA090381, NIH P01 CA163227, the Intramural Program of the National Institutes of Health, and the Prostate Cancer Foundation. The original abiraterone COU-AA-201 study was funded by Janssen Research &amp; Development. Taplin et al. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. J Clin Oncol, 2014. 32(33):3705-15</acknowledgement_statement><ic_specific_access_term>NCI Specific Terms: None
Data Use Limitations: The iNCI DAC recognizes the  Data Use Limitations of each consent group stated on the dbGaP study page. </ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_old_cert" gsr_mode_label="Unrestricted access (institution responded that the study is not sensitive without submitting a new Institutional Certification)"/><ConsentGroup uid="2615" CGType="cg_class_DS" title="Disease-Specific (Cancer, NPU)" name="DS-CA-NPU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>